Towa Pharmaceutical Co ( (JP:4553) ) has issued an update.
Towa Pharmaceutical Co., Ltd. announced a partial revision of its Basic Policy for the Development of an Internal Control System, effective April 1, 2025. The revisions aim to enhance the effectiveness and efficiency of operations, ensure compliance with laws, and improve risk management and corporate governance. This move is expected to strengthen the company’s internal controls and risk management framework, thereby supporting its long-term growth and stability.
More about Towa Pharmaceutical Co
Towa Pharmaceutical Co., Ltd., headquartered in Kadoma, Osaka, operates in the pharmaceutical industry, focusing on the development and distribution of generic drugs. The company is committed to enhancing corporate value and gaining stakeholder trust through effective corporate management and compliance with legal and ethical standards.
YTD Price Performance: -9.56%
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $914.9M
For a thorough assessment of 4553 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com